39 ASIAN LEGAL BUSINESS CHINA • 亚洲法律杂志-中国版 WWW.LEGALBUSINESSONLINE.COM/CHINA FLORENCE CHAN 陈婉殷 partner, Ogier 奥杰，合伙人 Florence Chan, a partner at Ogier, is a distinguished legal practitioner with extensive experience in corporate finance transactions. Renowned for her meticulous approach and strategic insight, Chan has been instrumental in advising on numerous key transactions. In the realm of mergers and acquisitions (M&A) and private equity, Chan has played pivotal roles in significant deals. For instance, she served as Cayman counsel to RRJ Capital in its recapitalisation buy-out merger of Singapore-based Fullerton Healthcare Corporation Limited. She also advised DCP Capital Partners, Ocean Link Partners, and Mr Rick Yan as Cayman counsel in connection with their take-private of 51jobs, valued at approximately $5.7 billion. Furthermore, Chan has made significant contributions in the capital markets arena, advising on high-profile IPOs. Her notable engagements include acting as Cayman counsel to Virax Biolabs Group Limited and Meihua International Medical Technologies in their IPOs on the Nasdaq Capital Market. Chan is also well-versed in handling U.S. SPAC listings, providing vital offshore legal advice in multiple IPOs for SPACs. Furthermore, Chan’s fluency in English, Cantonese, and Mandarin, along with her extensive legal expertise, make her a trusted advisor in navigating complex corporate transactions with precision and success. 陈婉殷是奥杰律师事务所合伙人，在企业融资交易领域 拥有丰富经验，以其一丝不苟的工作方法和战略洞察力 著称。 在并购和私募股权领域，陈律师在一些重大交易中扮 演关键角色。例如，她作为开曼顾问为RRJ Capital服务， 参与了对总部位于新加坡的富乐医疗有限公司的重组并 购。她还作为开曼顾问为DCP Capital Partners、Ocean Link Partners和严凯先生提供服务，参与了他们对前程 无忧的私有化交易，该交易估值约为57亿美元。 她在资本市场领域也做出了重要贡献，为多个备受瞩 目的首次公开发行项目提供咨询。她的重要业绩包括作为 开曼顾问，为Virax Biolabs和美华国际医疗科技在纳斯 达克的首次公开发行提供服务。陈律师亦有就特殊目的 收购公司在美国上市提供离岸法律意见相关的丰富经验。 精通英语、粤语和普通话，加上丰富的法律专业知识， 使她能够精准、成功地处理复杂公司交易，是可信赖的法 律顾问。 RACHEL HUANG 黄颖 partner, Ogier 奥杰，合伙人 Rachel Huang, a partner in Ogier’s Corporate and Finance team in Hong Kong, brings a wealth of experience and expertise to her role. Her practice focuses on corporate finance transactions, including initial public offerings (IPOs), SPAC listings, de-SPAC transactions, pre-IPO investments, mergers and acquisitions (M&A), debt capital markets and bond restructuring work. Before joining Ogier, Huang honed her skills at a Londonheadquartered law firm, specialising in debt capital markets. Prior to this, she spent two years as a corporate lawyer at a leading Chinese law firm in Shanghai before relocating to Hong Kong. Rachel’s diverse background and international experience equip her with a unique perspective in advising clients on complex cross-border transactions. Fluent in Mandarin, English, and Cantonese, Huang’s language abilities facilitate effective communication and collaboration with clients across different jurisdictions. Huang has played a pivotal role in numerous key transactions, including advising Blue Safari Group Acquisition Corp. on its $50 million IPO on Nasdaq and its de-SPAC merger with Bitdeer Technologies Holding Company. She also advised Model Performance Acquisition Corp. on its $50 million IPO on Nasdaq and its $300 million de-SPAC merger with MultiMetaVerse. Huang is a Registered Foreign Lawyer regulated by the Law Society of Hong Kong. 黄颖是奥杰香港办公室公司融资部合伙人，拥有丰富的经 验和专业知识。她的执业涵盖公司融资交易，包括首次公 开发行、SPAC上市、de-SPAC交易、上市前融资、合并和 收购、债券资本市场和债券重组等领域。 在加入奥杰律师事务所之前，黄律师曾在总部位于伦 敦的律师事务所工作，专注于债券资本市场。在此之前，她 在上海的一家领先的中国律师事务所担任公司律师两年， 之后她搬到了香港。黄律师的多元背景和国际经验使她在 为客户提供复杂跨境交易咨询时具有独特的视角。 黄律师精通普通话、英语和粤语，能够与不同司法管 辖区的客户进行有效沟通和协作。 她在许多关键交易中扮演了核心角色，包括为Blue Safari Group Acquisition Corp. 在纳斯达克的5000 万美元IPO及其与比特小鹿科技集团的SPAC合并提供咨 询。她还为Model Performance Acquisition Corp. 的纳斯达克5000万美元IPO以及与元宇宙控股的3亿美 元SPAC合并提供了咨询。 黄律师是香港律师会监管的注册外国律师。 OFFSHORE CLIENT CHOICE
RkJQdWJsaXNoZXIy MjA0NzE4Mw==